121 related articles for article (PubMed ID: 38406943)
1. Survival Of Patients With Brain Metastases After Palliative Whole-Brain Radiotherapy - An Experience From A Single Institute.
Misbah D; Fawad-Ul-Qamar M; Khaleeq N; Zaida A; Ali Shah SZ; Sajjad K
J Ayub Med Coll Abbottabad; 2023; 35(4):599-602. PubMed ID: 38406943
[TBL] [Abstract][Full Text] [Related]
2. Radiosurgery for brain metastases from primary lung carcinoma.
Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
[TBL] [Abstract][Full Text] [Related]
3. Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic Radiosurgery.
Wilson TG; Robinson T; MacFarlane C; Spencer T; Herbert C; Wade L; Reed H; Braybrooke JP
Clin Oncol (R Coll Radiol); 2020 Jun; 32(6):390-396. PubMed ID: 32131980
[TBL] [Abstract][Full Text] [Related]
4. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
8. Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001.
Churilla TM; Handorf E; Collette S; Collette L; Dong Y; Aizer AA; Kocher M; Soffietti R; Alexander BM; Weiss SE
Ann Oncol; 2017 Oct; 28(10):2588-2594. PubMed ID: 28961826
[TBL] [Abstract][Full Text] [Related]
9. Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery.
Rava P; Leonard K; Sioshansi S; Curran B; Wazer DE; Cosgrove GR; Norén G; Hepel JT
J Neurosurg; 2013 Aug; 119(2):457-62. PubMed ID: 23662828
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
11. Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer.
Noel G; Medioni J; Valery CA; Boisserie G; Simon JM; Cornu P; Hasboun D; Ledu D; Tep B; Delattre JY; Marsault C; Baillet F; Mazeron JJ
Lung Cancer; 2003 Sep; 41(3):333-43. PubMed ID: 12928124
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
13. Recent trends of characteristics and treatments in adults with newly diagnosed brain metastases.
Koide Y; Nagai N; Miyauchi R; Kitagawa T; Aoyama T; Shimizu H; Hashimoto S; Tachibana H; Kodaira T
Jpn J Clin Oncol; 2023 Jun; 53(7):572-580. PubMed ID: 37002189
[TBL] [Abstract][Full Text] [Related]
14. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
15. Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype.
Matsunaga S; Shuto T; Kawahara N; Suenaga J; Inomori S; Fujino H
J Neurosurg; 2010 Dec; 113 Suppl():65-72. PubMed ID: 21121788
[TBL] [Abstract][Full Text] [Related]
16. Gamma knife radiosurgery for brain metastases: do patients benefit from adjuvant external-beam radiotherapy? An 18-month comparative analysis.
Jawahar A; Willis BK; Smith DR; Ampil F; Datta R; Nanda A
Stereotact Funct Neurosurg; 2002; 79(3-4):262-71. PubMed ID: 12890985
[TBL] [Abstract][Full Text] [Related]
17. Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.
Jeene PM; de Vries KC; van Nes JGH; Kwakman JJM; Wester G; Rozema T; Braam PM; Zindler JD; Koper P; Nuyttens JJ; Vos-Westerman HA; Schmeets I; Niël CGHJ; Hutschemaekers S; van der Linden YM; Verhoeff JJC; Stalpers LJA
Acta Oncol; 2018 May; 57(5):637-643. PubMed ID: 29276848
[TBL] [Abstract][Full Text] [Related]
18. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
[TBL] [Abstract][Full Text] [Related]
19. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
20. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.
Johung KL; Yeh N; Desai NB; Williams TM; Lautenschlaeger T; Arvold ND; Ning MS; Attia A; Lovly CM; Goldberg S; Beal K; Yu JB; Kavanagh BD; Chiang VL; Camidge DR; Contessa JN
J Clin Oncol; 2016 Jan; 34(2):123-9. PubMed ID: 26438117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
